General Information of Binding Target of SBP (BTS) (ID: ST00321)
BTS Name
Complement C3
Synonyms
C3bc; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]
BTS Type
Protein
Gene Name
C3
Organism
Cavia porcellus (Guinea pig)
Function
C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.; Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. In chronic inflammation, acts as a chemoattractant for neutrophils (By similarity).; [C3-beta-c]: Acts as a chemoattractant for neutrophils in chronic inflammation.
UniProt ID
P12387
UniProt Entry
CO3_CAVPO
PFam
PF00207 ; PF07703 ; PF07677 ; PF01821 ; PF17790 ; PF01835 ; PF17791 ; PF17789 ; PF01759 ; PF07678
Gene ID
100135462
Sequence
MGPAAGPSLLLLLLASVSLALGDPMYSIITPNILRLENEETVVLEAHEVQGDIPVTVTVH
DFPAKKNVLSSEKTVLTSATGYLGTVTIKIPASKEFKSDKGRKLVVVQAAFGGTQLEKVV
LVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVDSDLLPVGRTIIVTIETPDGIPIKRDTLS
SNNQHGILPLSWNIPELVNMGQWKIQAFYENSPKQVFSAEFEVKEYVLPSFEVLVEPTEK
FYYIDDPKGLEVNIIARFLYGKNVDGTAFVIFGVQDGDQRISLAQSLTRVVIEDGSGEVV
LSRQVLLDGVQPSRPEALVGKSLYVSVTVILHSGSDMVEAERSGIPIVTSPYQIHFTKTP
KYFKPAMPFEIMVLVTNPDGSPAPHVPVVTQGSNVQSLTQADGVARLSINTPNTRQPLSV
TVQTKKGGIPDARQAINTMQALPYTTMYNSNNYLHLSMPRTELKPGETINVNFHLRSDPN
QEAKIRYYTYLIMNKGKLLKVGRQPREPGQALVVLPMPITKELIPSFRLVAYYTLIGASA
QREVVADSVWADVRDSCVGTLVVKGGSGKDGQDKRQQHLPRQQMTLRIEGNQGARVGLVA
VDKGVFVLNKKHKLTQSKIWDVVEKADIGCTPGSGKDYAGVFTDAGLSFKSSKAGLQTAQ
REGLDCPKPAARRRRSVQLMERRMDKAGKYKSKELRRCCEDGMRENPMQFSCQRRARYVS
LGEACVKAFLDCCTYMAQLRQQHRREQNLGLARSDMDEDIIPEEDIISRSQFPESWLWTI
EELKEPERNGISTKTMNIFLKDSITTWEILAVSLSDKKGICVADPFEVTVMQDFFIDLRL
PYSVVRNEQVEIRAVLYNYREAQSLKVRVELLHNPAFCSLATAKKRHTQTVTIGPKSSVA
VPYVLVPLKIGLQEVEVKAAVYNYFISDGVKKTLKVVPEGMRVNKTVAIRTLNPEQLGQG
GVQREEIPAADLSDQVPDTDSETKILLQGTPVAQMAEDAVDAERLKHLIITPSGCGEQNM
IGMTPTVIAVHYLDQTEQWEKFGLEKRQEALNLINRGYTQQLAFKQPNWAYAAFKNRASS
TWLTAYVVKVFSLAANLIGIDSEVLCGAVKWLILEKQKPDGVFQEDGPVIHQEMIGGVRT
AQEADVSLTAFVLIALQEAKDICRAQVNNLEANINKAGDYIESRYADVRRPYTLAIAGYA
LALLERLNGATLQKFLNAATEKNRWEEARQKLYSVEATSYALLALLLLKDFDAVPPVVRW
LNEQRYYGRGYGSTQATFMVFQALAQYQTDVPDHKDLNMEVALQLPSRSSPSKFRLVWEA
GSLLRSEATKQNEGFKLTAKGKGQGTLSVVAVYYAKTKRKVVCKNFDLRVTLKPAPDTVK
KPQEAKSTMILGICTRYLGDQDATMSILDISMMTGFIPDTDDLKLLATGVDRYISKYEMN
KDFSKNTLIIYLDKVSHSEEECLSFKIHQFFNVGLIQPGSVKVYSYYNLDETCTQFYHPE
KEDGMLNKLCHKDLCRCAEENCFIQLPEKITLDERLEKACEPGVDYVYKTKLLKMELSDD
FDEYIMTIEQVIKSGSDEVQAGKERRFISHIKCRDALHLKEGKHYLMWGLSSDLWGERPN
MSYIIGKDTWVEAWPEAEECQDEENQQQCQDLGTFTENMVVFGCPN
Sequence Length
1666
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
scFv anti-C3 BA8 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 BD12 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 BD3 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KA8 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KC11 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KC3 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KE11 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KF7 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 KG3 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 MA11 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 MA9 Research Binder N.A. Research tool
SBP Info
[1]
scFv anti-C3 MF9 Research Binder N.A. Research tool
SBP Info
[1]
References
1 Guinea pig C3 specific rabbit single chain Fv antibodies from bone marrow, spleen and blood derived phage libraries. J Immunol Methods. 2000 Mar 6;236(1-2):117-31.